NCNA
NUCANA SP ADR (NCNA)
NASDAQ
$1.77+$0.04 (+2.25%)
Price as of Jun 23, 2026 7:53 PM EDT
  • $7.6M
    Market Cap
  • -89.71%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-12.7M
-29.31%
-18.0M
-28.11%
-25.1M
-31.20%
-36.4M
-1.11%
Depreciation and Amortization Expense
274,000
-47.51%
522,000
-9.22%
575,000
-21.45%
732,000
-22.29%
Total Operating Expenses
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Profit
-20.1M
-11.83%
-22.8M
-30.43%
-32.8M
-16.20%
-39.1M
-18.33%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
2.7M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-29.4M
+54.51%
-19.0M
-31.25%
-27.6M
-13.71%
-32.0M
-21.00%
Income Taxes
-1.2M
-66.18%
-3.5M
-21.46%
-4.4M
-31.62%
-6.4M
-11.51%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-29.4M
+54.51%
-19.0M
-31.25%
-27.6M
-13.71%
-32.0M
-21.00%
Net Income from Continuing Operations Applicable to Common
-29.4M
+54.51%
-19.0M
-31.25%
-27.6M
-13.71%
-32.0M
-21.00%
Basic EPS and Net Income
0.00
+100.00%
-0.26
-50.94%
-0.53
N/A
N/A
N/A
Diluted EPS and Net Income
0.00
+100.00%
-0.26
-50.94%
-0.53
N/A
N/A
N/A
Basic Weighted Average Shares
11.2B
+15,038.66%
74.2M
+41.12%
52.6M
+0.65%
52.2M
+0.37%
Diluted Weighted Average Shares
11.2B
+15,038.66%
74.2M
+41.12%
52.6M
+0.65%
52.2M
+0.37%
Balance Sheet
Cash and Cash Equivalents
24.3M
+259.33%
6.7M
-60.82%
17.2M
-58.90%
41.9M
-30.45%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
24.3M
+259.33%
6.7M
-60.82%
17.2M
-58.90%
41.9M
-30.45%
Total Current Assets
26.9M
+119.01%
12.3M
-50.98%
25.0M
-54.44%
54.9M
-23.31%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
658,000
+234.01%
197,000
-62.19%
521,000
-39.84%
866,000
+1.76%
Total Long-Term Assets
3.0M
+18.49%
2.5M
-10.14%
2.8M
-16.26%
3.3M
-43.12%
Total Assets
29.8M
+101.94%
14.8M
-46.88%
27.8M
-52.26%
58.3M
-24.81%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
4.8M
-44.69%
8.7M
-31.63%
12.7M
-34.36%
19.3M
+64.82%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
714,000
+363.64%
154,000
-37.90%
248,000
-43.89%
442,000
+110.48%
Total Liabilities
5.5M
-37.56%
8.8M
-31.75%
12.9M
-34.57%
19.8M
+65.62%
Retained Earnings
-252.3M
+12.50%
-224.3M
+7.99%
-207.7M
+15.03%
-180.6M
+20.60%
Total Stockholders Equity
24.3M
+308.58%
6.0M
-60.01%
14.9M
-61.33%
38.5M
-41.26%
Total Shares Outstanding
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash Flow
Cash from Operating Activities
-7.5M
-60.94%
-19.1M
-27.69%
-26.4M
+14.17%
-23.2M
-2.80%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
159,000
+101.27%
79,000
-97.26%
2.9M
+2,306.67%
120,000
+103.37%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
25.0M
+205.55%
8.2M
+15,541.51%
-53,000
-67.08%
-161,000
+64.29%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-131.60%
+47.51%
-89.22%
+38.94%
-64.21%
+36.09%
-47.18%
+7.83%
Return on Equity
-193.87%
+6.34%
-182.30%
+76.12%
-103.51%
+68.18%
-61.55%
+25.11%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
5.60
+295.97%
1.42
-28.29%
1.97
-30.60%
2.84
-53.47%
Cash Ratio
5.06
+549.68%
0.78
-42.69%
1.36
-37.39%
2.17
-57.80%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow